Search results
259 Results for 'Synthetic Biology'
- Technologies (19)
- Collaborations (0)
- Team (0)
- News (194)
- Events (0)
- Multimedia (46)
- Publications (0)
- Jobs (0)
Technologies 19
-
MRBL: Next-Generation Gene Therapy for Molecular Skin Rejuvenation
The next-generation gene therapy for molecular skin rejuvenation combines a comprehensive target gene prediction with a novel transdermal delivery approach for therapeutic adenovirus-associated viruses. The platform targets monogenic disease indications in the skin, and extends the same targets to the treatment of common skin aging conditions. -
Circe: Tailored Fats for Food Applications
A fermentation-based platform that uses greenhouses gases to produce food-grade fats without the use of plants or animals. The Wyss Institute is de-risking this technology and is seeking strategic partnerships with companies and individuals who are interested in assisting with its development and commercialization. -
eRNA: Controlled Enzymatic RNA Oligonucleotide Synthesis
Synthetic RNA oligonucleotides designed as specific successions of the four nucleobases A, U, G, and C that mimic naturally occurring RNA species are the key components of diverse RNA-based therapies. These include RNA therapeutics that can partially or completely turn off the expression of disease-causing genes (antisense and interfering RNAs), help replace or supplement dysfunctional... -
Athlete-Derived Probiotics
Elite athletes possess extraordinary physical abilities enabling them to reach peak performances and recover quickly. The question is, can we extract information from their biology and use it to boost the performance level and speed up recovery of every-day-athletes? Research in different laboratories over the past years has discovered potential connections between the composition of... -
Circe: Transforming Greenhouse Gases into Biodegradable Products
Circe is a platform technology that uses engineered microbes to produce valuable, biodegradable synthetic polymers from greenhouse gases, minimizing the environmental impact of manufacturing. Potential applications include biodegradable plastics and packaging, energy-efficient agriculture, clean personal care products, and more. Circe is a platform technology that uses engineered microbes to produce valuable, biodegradable synthetic polymers from greenhouse gases, minimizing the environmental impact of manufacturing. Potential applications include biodegradable plastics and packaging, energy-efficient agriculture, clean personal care products, and more. -
DNA Data Storage
The genetic material DNA has garnered considerable interest as a medium for digital information storage because its density and durability are superior to those of existing silicon-based storage media. For example, DNA is at least 1000-fold more dense than the most compact solid-state hard drive and at least 300-fold more durable than the most stable...
News 194
Multimedia 46
-
Audio/PodcastHarnessing the Power of Artificial Intelligence & Synthetic Biology To Usher In A New Age of Drug Discovery: Jim Collins3 Takeaways features intimate conversations and insights from the world’s best thinkers, business leaders, writers, politicians, scientists, and other newsmakers. Each episode ends with the 3 key takeaways the leading figure has learned over their career. It’s hosted by Lynn Thoman. James Collins, Wyss Core Faculty member and co-inventor of the technology behind Covid vaccines,... -
Video/AnimationCirce: Using Microbes to Make Biodegradable ProductsCurrent manufacturing methods release harmful greenhouse gases and pollution, and many of the products produced do not biodegrade, damaging our ecosystems even further. What if we could turn greenhouse gases into biodegradable products? Researchers at the Wyss Institute are using synthetic biology to make this a reality. Credit: Wyss Institute at Harvard University -
Video/AnimationGeorge Church in the Xchange: Curiosity-Driven Science, Technology, And SocietyIn this episode of the Xchange, we hear from George Church, a true pioneer of synthetic biology and genomics. George will share possible silver linings of the COVID-19 pandemic, draw parallels between personalized medicine and personalized learning and explore what it means to really think outside of the box. A new virtual interview series from... -
Video/AnimationEnzymatic DNA Synthesis (EDS) for Data StoragePostdoctoral Fellow, Henry Lee, presents a Wyss Institute Validation Project that is developing a sustainable, low-cost approach for writing large amounts of digital information in DNA. This could one day replace current data storage methods, which are energy intensive and use large amounts of nonrenewable resources. Credit: Wyss Institute at Harvard University -
Video/AnimationBeating Back the CoronavirusWhen the coronavirus pandemic forced Harvard University to ramp down almost all on-site operations, members of the Wyss Institute community refocused their teams, and formed new ones, in order to fight COVID-19 on its multiple fronts. These efforts include building new pieces of personal protective equipment that were delivered to frontline healthcare workers, developing new... -
Video/AnimationImproving Canine HealthspanA Wyss Institute technology that can treat multiple age-related diseases is now being developed by Rejuvenate Bio into a treatment for mitral valve disease and other deadly conditions in dogs, with the goal of helping man’s best friend live longer, healthier lives. Credit: Wyss Institute at Harvard University